Related Experiment Video
Updated: Sep 30, 2025

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
Published on: April 16, 2013
In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia
Nadine Rüchel1, Vera H Jepsen1, Daniel Hein1
1Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Moorenstraße 5, 40225, Duesseldorf, Germany.
Pediatric B cell precursor acute lymphoblastic leukemia (BCP ALL) often starts before birth. Future prevention may involve modulating the immune system to target preleukemic cells.
Area of Science:
- Pediatric Oncology
- Immunology
- Cancer Genomics
Background:
- Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, typically diagnosed between ages 2-5.
- Leukemia development often involves a prenatal 'first hit' creating preleukemic cells, followed by a postnatal 'second hit'.
- Genetic factors (germline and somatic mutations) and immune dysregulation are implicated in ALL pathogenesis.
Purpose of the Study:
- To review the prenatal origins of pediatric B cell precursor ALL (BCP ALL).
- To explore potential preventive strategies targeting preleukemic cells.
- To discuss the role of the immune system, including NK and Th cells, in ALL development and control.
Main Methods:
- Review of existing literature on the prenatal origin of pediatric BCP ALL.
- Analysis of genetic predisposition and the 'second hit' hypothesis.
- Discussion of immune system involvement and potential immunomodulatory interventions.
Main Results:
- Preleukemic cells can emerge in utero, remaining clinically silent.
- A dysregulated immune response, potentially linked to infections, may act as a co-factor in leukemia onset.
- Natural killer (NK) and T helper (Th) cells may play a role in controlling preleukemic cells.
Conclusions:
- Identifying the cell of origin for preleukemia could inform prevention strategies.
- Immune system modulation for prolonged immunosurveillance of preleukemic clones is a potential future preventive approach.
- Understanding prenatal origins and immune interactions is key to developing novel preventive therapies for pediatric BCP ALL.
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cells of the Adaptive Immune Response
Development of the Lymphatic System
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...

